Risk and safety profile in checkpoint inhibitors on non-small-cell lung cancer: A systematic review

Treating non-small-cell lung cancer (NSCLC) has gained increased importance in recent years due to the high mortality rate and dismal five-year survival rate. Immune checkpoint inhibitors (ICI) are a promising approach with exceptional outcomes in NSCLC thanks to the antigenic nature of cells. Conve...

书目详细资料
主要作者:	Majernikova, SM
格式:	Journal article
语言:	English
出版:	Taylor and Francis Group 2024

相似书籍

Risk and safety profile in checkpoint inhibitors on non-small-cell lung cancer: A systematic review
由: Sara Maria Majernikova
出版: (2024-12-01)

Advances in Pseudoprogression of Immune Checkpoint Inhibitors  in Non-small Cell Lung Cancer
由: Yajun TONG, et al.
出版: (2024-04-01)

Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer
由: Gen Lin, et al.
出版: (2024-02-01)

Circulating predictive markers of immune checkpoint inhibitors in non-small cell lung cancer
由: A. A. Musaelyan, et al.
出版: (2021-11-01)

Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study
由: Jia Feng, et al.
出版: (2024-01-01)

Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?
由: Kartik Sehgal, et al.
出版: (2020-05-01)

Survival and biomarkers for cachexia in non‐small cell lung cancer receiving immune checkpoint inhibitors
由: Daiki Murata, et al.
出版: (2023-10-01)

Effectiveness of immune checkpoint inhibitor therapy on bone metastases in non-small-cell lung cancer
由: Annalise G. Abbott, et al.
出版: (2024-06-01)

The efficacy and safety of immune-checkpoint inhibitors plus chemotherapy versus chemotherapy for non-small cell lung cancer: An updated systematic review and meta-analysis.
由: Jing Kang, et al.
出版: (2024-01-01)

Efficacy and safety of immune checkpoint inhibitors for EGFR mutated non-small cell lung cancer: a network meta-analysis
由: Lin Zhu, et al.
出版: (2024-12-01)

Efficacy and safety of immune checkpoint inhibitors in elderly patients with advanced non-small cell lung cancer: a systematic review and meta-analysisResearch in context
由: Jiacheng Yao, et al.
出版: (2025-03-01)

Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors
由: Martina Catalano, et al.
出版: (2024-11-01)

Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer
由: Aram A. Musaelyan, et al.
出版: (2024-10-01)

Obesity paradox in patients with non‐small cell lung cancer undergoing immune checkpoint inhibitor therapy
由: Ji Hyun Lee, et al.
出版: (2023-12-01)

A nomogram model for predicting the risk of checkpoint inhibitor‐related pneumonitis for patients with advanced non‐small‐cell lung cancer
由: Yao Zhang, et al.
出版: (2023-08-01)

The Impact of Age on Treatment Responses in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
由: Gülin Alkan Şen, et al.
出版: (2024-12-01)

Immune checkpoint inhibitors and myocarditis in advanced non-small cell lung cancer: a nationwide cohort study
由: Fu-Xiao Li, et al.
出版: (2025-02-01)

Immune Checkpoint Inhibitor Score Predicts Survival Benefit of Immunotherapy in Patients with Non-small Cell Lung Cancer
由: Da Hyun Kang, et al.
出版: (2024-10-01)

Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non‐small cell lung cancer
由: Jie Zhao, et al.
出版: (2024-05-01)

Identification of immune-related gene signature for non-small cell lung cancer patients with immune checkpoint inhibitors
由: Li Wang, et al.
出版: (2024-03-01)

Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non–small cell lung cancer
由: Uiju Cho, et al.
出版: (2024-03-01)

Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer
由: Chi Nguyen, et al.
出版: (2023-01-01)

The relative risk of immune checkpoint inhibitor pneumonitis in advanced non-small- cell lung cancer: Meta-analyses of controlled clinical trials.
由: Ying Kong, et al.
出版: (2024-01-01)

The relative risk of immune checkpoint inhibitor pneumonitis in advanced non-small- cell lung cancer: Meta-analyses of controlled clinical trials
由: Ying Kong, et al.
出版: (2024-01-01)

Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system
由: Xueyan Liang, et al.
出版: (2024-04-01)

Efficacy and Safety Evaluation of Immune Checkpoint Inhibitors in Combination With Chemotherapy for Extensive Small Cell Lung Cancer: Real‐World Evidence
由: Yuta Yamanaka, et al.
出版: (2024-12-01)

Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors
由: Marco Meazza Prina, et al.
出版: (2024-12-01)

Role of the HGF/c-MET pathway in resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer
由: Assya Akli, et al.
出版: (2025-01-01)

Myasthenia gravis and concurrent myositis following PD-L1 checkpoint inhibitor for non-small cell lung cancer
由: Chun Seng Phua, et al.
出版: (2020-07-01)

Prognostic significance and response to immune checkpoint inhibitors of RIPK3, MLKL and necroptosis in non-small cell lung cancer
由: Nattaya Duangthim, et al.
出版: (2024-09-01)

The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patients
由: Ni Sun, et al.
出版: (2024-06-01)

The efficacy and safety of immune checkpoint inhibitors for patients with EGFR‐mutated non‐small cell lung cancer who progressed on EGFR tyrosine‐kinase inhibitor therapy: A systematic review and network meta‐analysis
由: Zhen Wang, et al.
出版: (2023-09-01)

Impact of bone metastasis on prognosis in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
由: Yonghua Zhu, et al.
出版: (2024-11-01)

Non–small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?
由: Yi Li, et al.
出版: (2024-04-01)

Quantification of preexisting lung ground glass opacities on CT for predicting checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients
由: Xinyue Wang, et al.
出版: (2024-02-01)

Cytokine release syndrome in non- small cell lung cancer patient receiving immune checkpoint inhibitors: A case report
由: Ana Geltar, et al.
出版: (2025-03-01)

YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer
由: Ling-Chen Li, et al.
出版: (2023-01-01)

Machine learning predicted fast progression after initiation of immune checkpoint inhibitors in advanced non-small cell lung cancer
由: Martin Stockler, et al.
出版: (2024-07-01)

Effect of Gender on Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Real-World Study
由: Teresa Calleja-Chucla, et al.
出版: (2025-02-01)

The association of nutritional and inflammatory biomarkers with overall survival in patients with non‐small‐cell lung cancer treated with immune checkpoint inhibitors
由: I. M. Horstman, et al.
出版: (2024-08-01)